Merck to pay up to $10M to settle old Coppertone suit; S&P keeps Abbott on watch pre-spinoff;

Did Valeant bid too high for Medicis? Analysts cite flagging scripts for lead drug, Solodyn. More | Follow @FiercePharma

> Merck ($MRK) agreed to pay up to $10 million to settle an old class-action lawsuit over Coppertone sunscreen products, which it acquired along with Schering-Plough in their 2009 merger. Report

> As Abbott Laboratories ($ABT) prepares to spin off its pharma unit as a separate company, AbbVie, Standard & Poor's says it's keeping the company on CreditWatch, at least until details of the post-spinoff company come clear. Report

> In opening Eisai's new U.K. production facility, executives said it would be a springboard for moving the epilepsy treatment Fycompa into new markets such as Russia and Africa. Report

> Pfizer ($PFE) cut the price of Viagra in Thailand by up to 30% as generic companies prepare to launch their versions next week. Report

> Pfizer Healthy Partnership is enlisting pharmacists to encourage patients to take their drugs as directed. Report

> Older adults in the South are prescribed antibiotics more often than patients elsewhere, a study found, suggesting that the infection-fighters may be overused in that part of the country. Report

Medical Device News

 @FierceMedDev: EU proposes tougher medical device rules in light of breast implant scandal. More | Follow @FierceMedDev

 @DamianFierce: Smith & Nephew has issued a device failure warning for one of its all-metal hip implants. More | Follow @DamianFierce

> Mainstay Medical snags $20M for back pain device. More

> Custom Medical Specialties hit with Class I recall of surgical kits. News

> Stryker unleashes global recall of chest fluid pump device. Article

Biotech News

 @FierceBiotech: Tagging the lows: RNA biomarkers personalize depression treatment. More | Follow @FierceBiotech

 @RyanMFierce: Ouch. Cardiome doesn't have much to fall back on after this Afib program that Merck has dropped back in its lap. More | Follow @RyanMFierce

> Biogen races to FDA with positive PhIII data for hemophilia B drug. Article

> FDA seeks ways to boost antibacterial drug pipeline. Story

> Merck hands back heart-drug rights to struggling Cardiome. Item

Biomarkers News

> Marker picks out the right people for stroke therapy. More

> Genes power bowel cancer marker panel. News

> Cutting through the silence of heart disease. Article

Drug Delivery News

> Pulsing nanotubes pump out drugs. Story

> SkyePharma's Flutiform launches in Germany, Kyorin seeks OK in Japan. News

> Boston Scientific's stent opens blood vessels and European markets. Article

And Finally... Biologists discovered one way that biological clocks affect neuronal activity in the brain. Report

Suggested Articles

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.

By extending the tender offer for just six days, Roche seems confident it will receive positive reviews from U.S. and U.K. watchdogs in time.